S&P 500   3,311.72 (-0.30%)
DOW   29,044.88 (-0.48%)
QQQ   223.79 (-0.04%)
AAPL   318.05 (+0.11%)
FB   219.85 (-0.66%)
MSFT   166.09 (+0.24%)
NVDA   251.60 (+0.62%)
BABA   217.89 (-2.01%)
MU   59.48 (+0.52%)
GE   11.71 (+2.99%)
TSLA   566.11 (-0.61%)
AMD   51.23 (-0.39%)
T   38.57 (-1.23%)
NFLX   342.37 (+5.02%)
BAC   33.95 (-1.19%)
DIS   141.57 (-1.69%)
GILD   63.14 (-0.46%)
S&P 500   3,311.72 (-0.30%)
DOW   29,044.88 (-0.48%)
QQQ   223.79 (-0.04%)
AAPL   318.05 (+0.11%)
FB   219.85 (-0.66%)
MSFT   166.09 (+0.24%)
NVDA   251.60 (+0.62%)
BABA   217.89 (-2.01%)
MU   59.48 (+0.52%)
GE   11.71 (+2.99%)
TSLA   566.11 (-0.61%)
AMD   51.23 (-0.39%)
T   38.57 (-1.23%)
NFLX   342.37 (+5.02%)
BAC   33.95 (-1.19%)
DIS   141.57 (-1.69%)
GILD   63.14 (-0.46%)
S&P 500   3,311.72 (-0.30%)
DOW   29,044.88 (-0.48%)
QQQ   223.79 (-0.04%)
AAPL   318.05 (+0.11%)
FB   219.85 (-0.66%)
MSFT   166.09 (+0.24%)
NVDA   251.60 (+0.62%)
BABA   217.89 (-2.01%)
MU   59.48 (+0.52%)
GE   11.71 (+2.99%)
TSLA   566.11 (-0.61%)
AMD   51.23 (-0.39%)
T   38.57 (-1.23%)
NFLX   342.37 (+5.02%)
BAC   33.95 (-1.19%)
DIS   141.57 (-1.69%)
GILD   63.14 (-0.46%)
S&P 500   3,311.72 (-0.30%)
DOW   29,044.88 (-0.48%)
QQQ   223.79 (-0.04%)
AAPL   318.05 (+0.11%)
FB   219.85 (-0.66%)
MSFT   166.09 (+0.24%)
NVDA   251.60 (+0.62%)
BABA   217.89 (-2.01%)
MU   59.48 (+0.52%)
GE   11.71 (+2.99%)
TSLA   566.11 (-0.61%)
AMD   51.23 (-0.39%)
T   38.57 (-1.23%)
NFLX   342.37 (+5.02%)
BAC   33.95 (-1.19%)
DIS   141.57 (-1.69%)
GILD   63.14 (-0.46%)
Log in
(Ad)
What if you could buy one tiny stock today for $10 - at the center of a growing tech industry - that experts believe will explode a massive 77,400%? Wall Street legend Paul Mampilly recently identified this as the stock of the century. Buying up a handful of shares of this small company now could change your life and even make you millions.

NASDAQ:BCPC - Balchem Stock Price, Forecast & News

$107.28
+0.27 (+0.25 %)
(As of 01/23/2020 12:37 PM ET)
Add
Compare
Today's Range
$105.43
Now: $107.28▼
$107.49
50-Day Range
$98.98
MA: $103.39▼
$108.49
52-Week Range
$79.06
Now: $107.28▼
$109.44
Volume1,302 shs
Average Volume89,951 shs
Market Capitalization$3.45 billion
P/E Ratio43.61
Dividend Yield0.49%
Beta1.18
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Read More…

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Chemicals & allied products
Sub-IndustrySpecialty Chemicals
SectorBasic Materials
Current SymbolNASDAQ:BCPC
Previous Symbol
CUSIP05766520
CIK9326
Webhttp://www.balchem.com/
Phone845-326-5600

Debt

Debt-to-Equity Ratio0.32
Current Ratio3.33
Quick Ratio2.31

Price-To-Earnings

Trailing P/E Ratio43.61
Forward P/E Ratio33.95
P/E GrowthN/A

Sales & Book Value

Annual Sales$643.68 million
Price / Sales5.36
Cash Flow$4.43 per share
Price / Cash Flow24.19
Book Value$21.45 per share
Price / Book5.00

Profitability

EPS (Most Recent Fiscal Year)$3.01
Net Income$78.57 million
Net Margins12.43%
Return on Equity14.01%
Return on Assets9.68%

Miscellaneous

Employees1,135
Outstanding Shares32,170,000
Market Cap$3.45 billion
Next Earnings Date2/27/2020 (Estimated)
OptionableOptionable

Receive BCPC News and Ratings via Email

Sign-up to receive the latest news and ratings for BCPC and its competitors with MarketBeat's FREE daily newsletter.

NASDAQ:BCPC Rates by TradingView

(Ad)

If you're looking to potentially make 1,000% in gains, then you NEED this biotech stock. This company discovered a medical breakthrough that may end heart attacks FOREVER! Estimated annual sales are $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, the stock price could double overnight. But you must be onboard BEFORE FDA approval.

Balchem (NASDAQ:BCPC) Frequently Asked Questions

What is Balchem's stock symbol?

Balchem trades on the NASDAQ under the ticker symbol "BCPC."

How often does Balchem pay dividends? What is the dividend yield for Balchem?

Balchem announced an annual dividend on Wednesday, December 18th. Shareholders of record on Monday, December 30th will be given a dividend of $0.52 per share on Friday, January 17th. This represents a yield of 0.51%. The ex-dividend date of this dividend is Friday, December 27th. This is a boost from Balchem's previous annual dividend of $0.47. View Balchem's Dividend History.

How were Balchem's earnings last quarter?

Balchem Co. (NASDAQ:BCPC) released its quarterly earnings results on Tuesday, November, 5th. The basic materials company reported $0.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.74 by $0.07. The basic materials company earned $158.60 million during the quarter, compared to the consensus estimate of $166.42 million. Balchem had a net margin of 12.43% and a return on equity of 14.01%. The business's revenue was up 2.3% on a year-over-year basis. During the same period in the prior year, the firm earned $0.73 earnings per share. View Balchem's Earnings History.

When is Balchem's next earnings date?

Balchem is scheduled to release their next quarterly earnings announcement on Thursday, February 27th 2020. View Earnings Estimates for Balchem.

What price target have analysts set for BCPC?

3 brokers have issued 12 month target prices for Balchem's stock. Their forecasts range from $100.00 to $110.00. On average, they expect Balchem's share price to reach $105.00 in the next twelve months. This suggests that the stock has a possible downside of 2.1%. View Analyst Price Targets for Balchem.

What is the consensus analysts' recommendation for Balchem?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Balchem in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Balchem.

What are Wall Street analysts saying about Balchem stock?

Here are some recent quotes from research analysts about Balchem stock:
  • 1. According to Zacks Investment Research, "Balchem Corporation provides state-of-the-art solutions and the finest quality products for a range of industries worldwide. Balchem Company consists of four business segments: Human Nutrition & Health; Animal Nutrition & Health; Specialty Products; and Industrial Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market. The Industrial Products segment manufactures and supplies certain derivative products into industrial applications. " (1/3/2020)
  • 2. HC Wainwright analysts commented, "Valuation methodology, risks and uncertainties. We utilize a comparable universe-derived EV-to-EBITDA multiple approach. EV-to-EBITDA multiple to our 2019 diluted EBITDA per share of $3.64, we derive a target of $110 per share. Risks include, but are not limited to: (1) slower-than-anticipated growth in Balchem’s base businesses; (2) a global fracking industry slowdown; (3) inability to launch new nutrition segment products; and (4) failure by Balchem’s partner Curemark to obtain approval for its autism drug candidate." (5/6/2019)

Has Balchem been receiving favorable news coverage?

News articles about BCPC stock have been trending extremely negative this week, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Balchem earned a coverage optimism score of -4.0 on InfoTrie's scale. They also assigned news coverage about the basic materials company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Balchem.

Who are some of Balchem's key competitors?

What other stocks do shareholders of Balchem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Balchem investors own include Opko Health (OPK), CVS Health (CVS), Altria Group (MO), Starbucks (SBUX), Walgreens Boots Alliance (WBA), AbbVie (ABBV), AT&T (T), Analog Devices (ADI), Glacier Bancorp (GBCI) and Methanex (MEOH).

Who are Balchem's key executives?

Balchem's management team includes the folowing people:
  • Mr. Theodore L. Harris, Chairman and Chief Exec. Officer (Age 54)
  • Mr. William A. Backus CPA, Chief Accounting Officer (Age 53)
  • Mr. Mark A. Stach, Gen. Counsel & Corp. Sec.
  • Mr. David F. Ludwig, VP & Gen. Mang. of Industrial Products (Age 61)
  • Mr. Carl Martin Bengtsson, Chief Financial Officer

Who are Balchem's major shareholders?

Balchem's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Tributary Capital Management LLC (0.65%), Capital Investment Services of America Inc. (0.40%), Scout Investments Inc. (0.27%), Bath Savings Trust Co (0.17%), Pennsylvania Trust Co (0.13%) and Wendell David Associates Inc. (0.09%). Company insiders that own Balchem stock include Daniel E Knutson, David F Ludwig and Scott C Mason. View Institutional Ownership Trends for Balchem.

Which institutional investors are selling Balchem stock?

BCPC stock was sold by a variety of institutional investors in the last quarter, including Tributary Capital Management LLC, Wendell David Associates Inc., Scout Investments Inc., Louisiana State Employees Retirement System, State of Alaska Department of Revenue, Nisa Investment Advisors LLC, Bath Savings Trust Co and Pennsylvania Trust Co. View Insider Buying and Selling for Balchem.

Which institutional investors are buying Balchem stock?

BCPC stock was purchased by a variety of institutional investors in the last quarter, including American Research & Management Co., First National Bank of Omaha and Zurcher Kantonalbank Zurich Cantonalbank . Company insiders that have bought Balchem stock in the last two years include Daniel E Knutson and Scott C Mason. View Insider Buying and Selling for Balchem.

How do I buy shares of Balchem?

Shares of BCPC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Balchem's stock price today?

One share of BCPC stock can currently be purchased for approximately $107.28.

How big of a company is Balchem?

Balchem has a market capitalization of $3.45 billion and generates $643.68 million in revenue each year. The basic materials company earns $78.57 million in net income (profit) each year or $3.01 on an earnings per share basis. Balchem employs 1,135 workers across the globe.View Additional Information About Balchem.

What is Balchem's official website?

The official website for Balchem is http://www.balchem.com/.

How can I contact Balchem?

Balchem's mailing address is 52 Sunrise Park Road, NEW HAMPTON NY, 10958. The basic materials company can be reached via phone at 845-326-5600 or via email at [email protected]


MarketBeat Community Rating for Balchem (NASDAQ BCPC)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  318 (Vote Outperform)
Underperform Votes:  287 (Vote Underperform)
Total Votes:  605
MarketBeat's community ratings are surveys of what our community members think about Balchem and other stocks. Vote "Outperform" if you believe BCPC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BCPC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Featured Article: Cryptocurrencies
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel